Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation.
about
Novel Stroke Therapeutics: Unraveling Stroke Pathophysiology and Its Impact on Clinical TreatmentsEnhanced phasic GABA inhibition during the repair phase of stroke: a novel therapeutic targetNo quiet surrender: molecular guardians in multiple sclerosis brainStepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in strokeA New-Age for Biologic Therapies: Long-Term Drug-Free Therapy with BiP?Intraarterial transplantation of human umbilical cord blood mononuclear cells is more efficacious and safer compared with umbilical cord mesenchymal stromal cells in a rodent stroke model.Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammationAstrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in miceAmyloid fibrils composed of hexameric peptides attenuate neuroinflammation.Protein polymer nanoparticles engineered as chaperones protect against apoptosis in human retinal pigment epithelial cellsB-lymphocyte-mediated delayed cognitive impairment following stroke.Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial.Therapeutic effects of systemic administration of chaperone αB-crystallin associated with binding proinflammatory plasma proteins.Effects of maternal immune activation on gene expression patterns in the fetal brainProteomic and epigenomic markers of sepsis-induced delirium (SID).Small Heat Shock Protein αB-Crystallin Controls Shape and Adhesion of Glioma and Myoblast Cells in the Absence of StressNovel roles for α-crystallins in retinal function and disease.Chaperone activity of small heat shock proteins underlies therapeutic efficacy in experimental autoimmune encephalomyelitis.Crystallins and neuroinflammation: The glial side of the story.Induction and phosphorylation of the small heat shock proteins HspB1/Hsp25 and HspB5/αB-crystallin in the rat retina upon optic nerve injuryαB-Crystallin regulates expansion of CD11b⁺Gr-1⁺ immature myeloid cells during tumor progression.Antiapoptotic properties of α-crystallin-derived peptide chaperones and characterization of their uptake transporters in human RPE cells.Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse BrainChaperone peptides of α-crystallin inhibit epithelial cell apoptosis, protein insolubilization, and opacification in experimental cataractsA Journey in Science: The Privilege of Exploring the Brain and the Immune System.Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammationSinomenine activates astrocytic dopamine D2 receptors and alleviates neuroinflammatory injury via the CRYAB/STAT3 pathway after ischemic stroke in mice.Effects of hyperbaric oxygen preconditioning on cardiac stress markers after simulated diving.Alpha beta-crystallin expression and presentation following infection with murine gammaherpesvirus 68.The protective and therapeutic function of small heat shock proteins in neurological diseases.Impact of diabetes on alpha-crystallins and other heat shock proteins in the eye.Janus faces of amyloid proteins in neuroinflammation.Peroxiredoxin sets the brain on fire after stroke.Therapeutic potential of α-crystallin.Regulation of αA- and αB-crystallins via phosphorylation in cellular homeostasis.Upregulation and phosphorylation of HspB1/Hsp25 and HspB5/αB-crystallin after transient middle cerebral artery occlusion in rats.Identification of highly connected hub genes in the protective response program of human macrophages and microglia activated by alpha B-crystallin.HspB5/αB-crystallin increases dendritic complexity and protects the dendritic arbor during heat shock in cultured rat hippocampal neurons.Replica exchange molecular dynamics simulations provide insight into substrate recognition by small heat shock proteinsActivation of Dopamine D2 Receptor Suppresses Neuroinflammation Through αB-Crystalline by Inhibition of NF-κB Nuclear Translocation in Experimental ICH Mice Model.
P2860
Q26800178-2EC93CD6-D1DE-4323-A6A9-35BB8B779606Q27303584-78308D64-051E-4E9C-92D9-474BDE4D79A9Q28084633-B10DAB0A-C3A8-4985-B673-2D8FA7BAE01DQ28238504-76C6721D-034A-4BA5-82AC-B9E4C83A12EFQ28730158-911974E2-CBAD-4ED9-985C-00137C17FF79Q30580565-C1E33DE7-A30C-4FE0-BF51-7D846BEFCE47Q33583306-D80605C0-3961-49A5-8A02-AFB56B2A9AD1Q33769818-95CB32F9-2F7B-42CC-804C-68BFD6915756Q34336783-028137C8-4746-4009-940B-99D1830B27A0Q34465338-60CB478F-95BD-446A-AB85-39BE05C3A01DQ35044819-D4369CAD-2155-49BF-AF61-E3A4721955CEQ35849942-DFE3EBD0-9527-49B1-85C6-F7E896AFBB06Q35879972-AE3DAF41-24AC-4899-909A-98A4ECD721F6Q35913929-32004D25-0013-4223-B86D-4E2437ED8D47Q36205083-10C0D573-5244-48BE-A86F-947C197F2F0CQ36224961-9566D0EC-6FBA-4E75-B71F-351EBA3019A2Q36319594-7EDFCE6B-599C-41E3-966F-D7DBBCB063FAQ36332934-12D39589-8072-4E68-A325-BAE80D651A41Q36345592-784C7C63-0BA7-450B-B0E4-1416710A7B59Q36373576-A1C6E861-2FD3-48A1-98CE-CC6DB1CF1302Q36482872-14D858D8-CDEC-4D32-A7BE-40AF2D8611C9Q36784092-A84E6F59-7D67-4B51-AD9A-83A30E7CB5ADQ36788361-EBD25EAA-23A1-4759-8C4C-A3BC4037C75DQ36812475-F49E679D-6BC5-4F50-B3C2-89BB171B4FF6Q37217037-52810F57-5813-409B-B04D-C61AAF50CB31Q37277276-18BAFD1D-2B7E-427C-8908-1ECABCE40513Q37326028-7380BF41-D2A5-4ED0-87C7-34BC20AC4EB8Q37411132-CCF57E78-F0F3-43E2-B8DB-E8A122EF80F8Q37670926-3F86D0EE-8396-4649-BFAC-D973DBCA6F16Q38008372-9C851985-4EF8-4B22-8EC8-CA00095AF045Q38069581-79FE4AA0-A30C-48A1-AD1C-4D84586BAFFDQ38202911-AA8515FE-2701-4E8F-8AA6-B8AEE2E46889Q38287139-499EC8F5-BE47-4D49-9929-1BCA0E8A19F6Q38404383-2C6C44F7-871B-40DD-99AB-A87298D5959CQ38554083-C32DB6BB-FF04-4275-AB7E-88AAFB5BAF69Q38829436-5E8F0FFF-4FCC-4CB2-B955-9D5E637D9920Q39034589-A6FB1DC7-61EA-4C09-93B9-0EFD7DCD1156Q40796472-7057CC95-98F4-4703-9BD2-4754A27D880BQ41142944-DD8BFB0E-E584-49DD-A6F9-6FE515C71EC2Q42875447-98862EE8-39B9-49B0-84BA-59B9B7AD1E43
P2860
Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Systemic augmentation of alpha ...... e onset via immune modulation.
@ast
Systemic augmentation of alpha ...... e onset via immune modulation.
@en
type
label
Systemic augmentation of alpha ...... e onset via immune modulation.
@ast
Systemic augmentation of alpha ...... e onset via immune modulation.
@en
prefLabel
Systemic augmentation of alpha ...... e onset via immune modulation.
@ast
Systemic augmentation of alpha ...... e onset via immune modulation.
@en
P2093
P2860
P356
P1476
Systemic augmentation of alpha ...... ke onset via immune modulation
@en
P2093
Ahmet Arac
Charlene Chen
Gary K Steinberg
Gregory W Albers
Jonathan B Rothbard
Lawrence Steinman
Sara E Brownell
P2860
P304
13287-13292
P356
10.1073/PNAS.1107368108
P407
P577
2011-07-26T00:00:00Z